MedTech's Subscription Shift: Surviving the Death of Hospital Capital Expenditures

This episode explores the pivotal shift in hospital procurement from traditional capital expenditures (CapEx) to subscription-based Device-as-a-Service (DaaS) models. We analyze why this change is occurring and detail its disruptive impact on medical device manufacturers, covering critical adjustments required in revenue recognition, sales compensation, customer relationships, and even product design to thrive in this new service-oriented landscape. Key Questions - Why are hospitals moving away from large, upfront equipment purchases? - What is included in a "Device-as-a-Service" (DaaS) contract? - How does subscription billing fundamentally change revenue recognition for MedTech companies? - What new sales commission structures are needed for a recurring revenue model? - How does the manufacturer-customer relationship evolve from transactional to a long-term partnership? - What are the implications for product design and durability in a DaaS model? - Can subscription models create a competitive advantage in new international markets? Navigating disruptive commercial models requires a forward-thinking global strategy. Pure Global offers end-to-end regulatory consulting for MedTech and IVD companies, helping you develop efficient pathways for market access and identify the best countries for expansion. Our unique combination of local expertise and advanced AI tools streamlines the creation of technical dossiers and keeps you ahead of regulatory changes. Let us help you turn market shifts into opportunities. Contact Pure Global at [email protected], visit us at https://pureglobal.com, or explore our FREE AI tools and database at https://pureglobal.ai.